CURIS INC CRIS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2000-08-01
CURIS INC insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| KAITIN KENNETH I | director | 2026-03-31 | Buy | 10,000 | $0.55 |
| Zung Jonathan B. | CDO | 2026-03-20 | Conversion | 66,667 | — |
| Hamdy Ahmed MD | CMO | 2026-03-20 | Conversion | 66,667 | — |
| Duvall Diantha | CFO | 2026-03-20 | Conversion | 66,666 | — |
| Dentzer James E | President & CEO | 2026-03-20 | Conversion | 133,333 | — |
| Rubin Marc | director | 2026-03-20 | Conversion | 26,667 | — |
Source: SEC EDGAR filings · CIK 0001108205 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.